Tsien Christina, Cao Yue, Chenevert Thomas
Department of Radiation Oncology, University of Michigan Hospital and Health Systems, Ann Arbor, MI.
Department of Radiation Oncology, University of Michigan Hospital and Health Systems, Ann Arbor, MI.
Semin Radiat Oncol. 2014 Jul;24(3):218-26. doi: 10.1016/j.semradonc.2014.02.004.
In this article, we review the clinical applications of diffusion magnetic resonance imaging (MRI) in the radiotherapy treatment of several key clinical sites, including those of the central nervous system, the head and neck, the prostate, and the cervix. Diffusion-weighted MRI (DWI) is an imaging technique that is rapidly gaining widespread acceptance owing to its ease and wide availability. DWI measures the mobility of water within tissue at the cellular level without the need of any exogenous contrast agent. For radiotherapy treatment planning, DWI improves upon conventional imaging techniques, by better characterization of tumor tissue properties required for tumor grading, diagnosis, and target volume delineation. Because DWI is also a sensitive marker for alterations in tumor cellularity, it has potential clinical applications in the early assessment of treatment response following radiation therapy.
在本文中,我们回顾了扩散磁共振成像(MRI)在几个关键临床部位放射治疗中的临床应用,包括中枢神经系统、头颈部、前列腺和子宫颈等部位。扩散加权MRI(DWI)是一种成像技术,因其操作简便且广泛可用而迅速得到广泛认可。DWI在无需任何外源性造影剂的情况下,在细胞水平测量组织内水的流动性。对于放射治疗计划,DWI通过更好地表征肿瘤分级、诊断和靶区勾画所需的肿瘤组织特性,对传统成像技术进行了改进。由于DWI也是肿瘤细胞密度改变的敏感标志物,它在放射治疗后治疗反应的早期评估中具有潜在的临床应用价值。